Cormorant Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-25,307
| Closed | -$178K | – | 78 |
|
|
2016
Q3 | $178K | Hold |
25,307
| – | – | 0.02% | 80 |
|
|
2016
Q2 | $206K | Buy |
25,307
+307
| +1% | +$2.5K | 0.03% | 80 |
|
|
2016
Q1 | $203K | Hold |
25,000
| – | – | 0.03% | 82 |
|
|
2015
Q4 | $302K | Hold |
25,000
| – | – | 0.04% | 80 |
|
|
2015
Q3 | $299K | Hold |
25,000
| – | – | 0.05% | 84 |
|
|
2015
Q2 | $458K | Buy |
+25,000
| New | +$458K | 0.06% | 76 |
|